A leading researcher with a particular interest in breast cancer, Dr. Mankoff has maintained more than 20 years of continuous funding from federal sources and has been recognized as a Susan G. Komen Scholar since 2012. Key research achievements include defining applications of FDG PET to breast cancer staging and response evaluation, translating novel tracers to early human trials, studying the in vivo biology of cancer metabolism, and imaging estrogen receptor expression in breast cancer using PET.
At the national level, Dr. Mankoff has served as a committee leader and scientific planning co-chair of the Eastern Cooperative Oncology Group and the American College of Radiology Imaging Network (ECOG-ACRIN). He is a former steering committee chair of the NCI Quantitative Imaging Executive Committee, former member of the NCI Clinical Trials Advisory Committee and former past president of the American Board of Nuclear Medicine.